WAM
MRNA icon

Weiss Asset Management’s Moderna MRNA Stock Holding History

Weiss Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-93,720
Closed -$4.76M – 770
2026
Q1 		$4.76M Buy
93,720
+61,500
+191% +$2.87M 0.08% 182
2025
Q4 		$950K Buy
+32,220
New +$875K 0.01% 419
2024
Q4 		– Sell
-36,954
Closed -$2.47M – 787
2024
Q3 		$2.47M Buy
+36,954
New +$3.39M 0.05% 301
2024
Q2 		– Sell
-13,498
Closed -$1.44M – 374
2024
Q1 		$1.44M Buy
+13,498
New +$1.36M 0.05% 178
2022
Q1 		– Sell
-8,370
Closed -$2.13M – 853
2021
Q4 		$2.13M Buy
+8,370
New +$2.45M 0.05% 438

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Weiss Asset Management's MRNA Position: Q2 2026 in Review

Weiss Asset Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 93,720 shares — an estimated $4.76M sold.

Weiss Asset Management first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $4.76M in Q1 2026. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Weiss Asset Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 93,720 Moderna shares in Q2 2026, an estimated $4.76M.
  • Weiss Asset Management first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • Weiss Asset Management's Moderna position peaked at $4.76M in Q1 2026.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.